These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 19261873

  • 21. Recent insights into the mode of action of memantine and ketamine.
    Johnson JW, Glasgow NG, Povysheva NV.
    Curr Opin Pharmacol; 2015 Feb; 20():54-63. PubMed ID: 25462293
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.
    Lipton SA.
    Curr Drug Targets; 2007 May; 8(5):621-32. PubMed ID: 17504105
    [Abstract] [Full Text] [Related]

  • 24. Antagonism of NMDA receptors by butanesulfonyl-homospermine guanidine and neuroprotective effects in in vitro and in vivo.
    Masuko T, Suzuki T, Miyake M, Kusama-Eguchi K, Kizawa Y, Tomono K, Kashiwagi K, Igarashi K, Kusama T.
    Neurosci Lett; 2012 Jan 11; 506(2):251-5. PubMed ID: 22119002
    [Abstract] [Full Text] [Related]

  • 25. The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801.
    Rammes G, Mahal B, Putzke J, Parsons C, Spielmanns P, Pestel E, Spanagel R, Zieglgänsberger W, Schadrack J.
    Neuropharmacology; 2001 May 11; 40(6):749-60. PubMed ID: 11369029
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. In vitro galantamine-memantine co-application: mechanism of beneficial action.
    Zhao X, Marszalec W, Toth PT, Huang J, Yeh JZ, Narahashi T.
    Neuropharmacology; 2006 Dec 11; 51(7-8):1181-91. PubMed ID: 17011596
    [Abstract] [Full Text] [Related]

  • 28. Memantine facilitates memory consolidation and reconsolidation in the day-old chick.
    Samartgis JR, Schachte L, Hazi A, Crowe SF.
    Neurobiol Learn Mem; 2012 May 11; 97(4):380-5. PubMed ID: 22425751
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Memantine does not show intracellular block of the NMDA receptor channel.
    Parsons CG, Gilling KE, Jatzke C.
    Eur J Pharmacol; 2008 Jun 10; 587(1-3):99-103. PubMed ID: 18456253
    [Abstract] [Full Text] [Related]

  • 31. Indistinguishable synaptic pharmacodynamics of the N-methyl-D-aspartate receptor channel blockers memantine and ketamine.
    Emnett CM, Eisenman LN, Taylor AM, Izumi Y, Zorumski CF, Mennerick S.
    Mol Pharmacol; 2013 Dec 10; 84(6):935-47. PubMed ID: 24101301
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan).
    Parsons CG, Gruner R, Rozental J, Millar J, Lodge D.
    Neuropharmacology; 1993 Dec 10; 32(12):1337-50. PubMed ID: 8152525
    [Abstract] [Full Text] [Related]

  • 34. Ethanol sensitivity of heteromeric NMDA receptors: effects of subunit assembly, glycine and NMDAR1 Mg(2+)-insensitive mutants.
    Mirshahi T, Woodward JJ.
    Neuropharmacology; 1995 Mar 10; 34(3):347-55. PubMed ID: 7630488
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Classics in Chemical Neuroscience: Memantine.
    Alam S, Lingenfelter KS, Bender AM, Lindsley CW.
    ACS Chem Neurosci; 2017 Sep 20; 8(9):1823-1829. PubMed ID: 28737885
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.